| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.6 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.49 | 0.6 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.25 | 0.4 |